Source: LHGDN

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.400 Biomarker LHGDN Rapamycin is associated with high eNOS in low shear regions, i.e. in atherogenic regions, protecting these regions against atherosclerosis, and is associated with a reduction of eNOS at high shear stress affecting vasomotion in these regions. 18079107

2008
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.400 GeneticVariation LHGDN Genetic risk of atherosclerotic renal artery disease: the candidate gene approach in a renal angiography cohort. 15326089

2004
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.400 GeneticVariation LHGDN These findings support the proposal that common genetic variations in the eNOS gene contribute to atherosclerosis susceptibility, presumably by effects on endothelial NO availability. 15007011

2004
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.400 GeneticVariation LHGDN The endothelial nitric oxide synthase Glu298Asp polymorphism has been suggested to play a role in the development of hypertension, atherosclerosis and coronary artery disease. 12359981

2002
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis 		0.400 AlteredExpression LHGDN Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide. 12364322

2002